Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Recombinant Asparaginase in Infants with ALL
NCT00983138Phase 2Completed
- Sponsor
- medac GmbH
- Start
- Jul 2009
- Primary completion
- Feb 2011
- Modality
- Replacement Enzymes
- Countries
- 2
01
Overview
A Phase 2 trial of Asparaginase in acute lymphoblastic leukemia (ALL), sponsored by medac GmbH. Started Jul 2009; status: completed.
02
Drugs
Asparaginase
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT00983138.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00983138.